This inventor holds 3 USPTO granted patents. Top assignee: Yale University. Active years: 2018-2024.
Company Filing History:
Years Active: 2018-2024
Title: Innovations in Cancer Treatment by Patrick McEnaney
Introduction
Patrick McEnaney is an accomplished inventor based in Jupiter, Florida. He has made significant contributions to the field of cancer treatment through his innovative research and development of synthetic antibody mimetic compounds. With a total of three patents to his name, McEnaney's work focuses on targeting cancer, particularly prostate cancer.
Latest Patents
McEnaney's latest patents include groundbreaking synthetic antibody mimetic compounds (SYAMS) that specifically target cancer cells. These compounds are designed to function as bifunctional and multifunctional agents, containing at least one cancer cell binding moiety that selectively binds to prostate-specific membrane antigen (PSMA). Additionally, they include an FC receptor binding moiety that modulates an FC immune receptor, preferably the FcγRI receptor. The unique design of these compounds allows them to bind selectively to cancer cells that upregulate PSMA. This interaction positions the FC receptor binding moiety in proximity to the Fc receptor, which can enhance the humoral immune response against cancer cells. The biological action of these compounds enables the immune regulation of cancer cells, including metastatic prostate cancer cells, leading to improved therapeutic outcomes for patients. Furthermore, the patents detail methods for using these compounds to treat cancer and reduce the likelihood of metastasis.
Career Highlights
Patrick McEnaney is affiliated with Yale University, where he continues to advance his research in cancer treatment. His innovative work has garnered attention in the scientific community, contributing to the ongoing fight against cancer.
Collaborations
Some of McEnaney's notable coworkers include David Spiegel and Kelly Fitzgerald, who collaborate with him in his research endeavors.
Conclusion
Patrick McEnaney's contributions to cancer treatment through his innovative synthetic antibody mimetic compounds represent a significant advancement in medical science. His work not only highlights the potential for targeted cancer therapies but also underscores the importance of collaboration in research.